Both in Pharmaceuticals
Dermata Therapeutics vs Apimeds Pharmaceuticals US
Over the past year DRMA returned −75.2% and APUS returned −88.0%; their daily moves had a correlation of 0.01.
DRMA −75.2% APUS −88.0%Growth of $1, one year, split-adjusted
| Metric | DRMA | APUS |
|---|---|---|
| Price | $0.8487 | $2.97 |
| Market cap | $4.2M | $4.5M |
| Today | +12.59% | +2.77% |
| 1 month | −23.5% | −35.3% |
| 6 months | −34.7% | −90.1% |
| Year to date | −63.4% | −81.9% |
| 1 year | −75.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | -$8.6M |
| Dividend yield | — | — |
| Volatility (60d) | 132.3% | 264.0% |
| Short % of float | 2.5% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).